| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.05 |